|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.350 USD | +5.47% |
|
+5.47% | -61.76% |
| 06-30 | ADC Therapeutics SA Completes Enrollment In LOTIS-7 Phase 1b ZYNLONTA Combination Trial | CI |
| 06-30 | ADC Therapeutics Completes Enrollment in LOTIS-7 Lymphoma Study | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +5.47% | +5.47% | +28.57% | -69.11% | -61.76% | -58.46% | -10.60% | -94.06% | - | 163M | |
| -3.42% | +10.05% | +27.81% | +18.88% | +40.11% | +58.59% | +87.70% | -23.03% | - | 57.82B | |
| -0.05% | -6.20% | -1.45% | +5.66% | +4.66% | +55.97% | +124.61% | +193.39% | +5,498.51% | 53.71B | |
| -2.14% | -7.78% | +10.26% | -26.77% | -38.26% | +4.46% | +421.65% | +290.91% | +842.63% | 23.8B | |
| -0.47% | -2.11% | +0.84% | -7.95% | -3.82% | -17.25% | -15.41% | -58.59% | - | 23.26B | |
| -0.56% | +10.26% | +27.17% | +6.27% | +25.06% | +44.03% | -3.86% | -71.45% | - | 20.7B | |
| -0.29% | -0.08% | +18.60% | +2.80% | -6.73% | +38.91% | -27.98% | -30.62% | +65.54% | 17.81B | |
| -4.55% | -8.65% | +46.82% | +115.03% | +197.38% | +194.32% | +349.58% | +1,658.57% | +630.60% | 16.9B | |
| -2.61% | +8.99% | +24.64% | +0.67% | +33.22% | +46.11% | +691.67% | - | - | 16.36B | |
| +0.23% | -0.77% | +5.06% | +25.75% | +27.04% | +26.37% | +187.16% | +219.82% | +559.72% | 13.96B | |
| -0.86% | -3.51% | +9.16% | +5.20% | -6.32% | +75.33% | +141.63% | +476.79% | - | 12.69B | |
| -8.69% | -12.30% | -2.62% | -34.85% | -21.33% | -43.51% | +542.99% | +95.73% | +82.25% | 11.7B | |
| -1.64% | +5.49% | +13.93% | -30.94% | -9.91% | -15.66% | +174.39% | +70.66% | - | 12.16B | |
| -2.74% | -5.33% | +12.58% | +22.93% | +26.47% | +111.42% | +130.06% | +315.94% | +712.54% | 11.22B | |
| -0.62% | -16.75% | -7.49% | +0.60% | +7.51% | +304.85% | +106.29% | +13.02% | +1,128.49% | 10.12B | |
| +0.02% | +0.13% | +0.49% | +18.34% | +23.23% | +49.44% | +199.13% | - | - | 9.83B | |
| -1.16% | +2.04% | +17.81% | -28.15% | +18.06% | +21.78% | +96.08% | -22.73% | - | 9.7B | |
| +0.01% | +0.50% | +138.92% | +110.99% | +80.26% | +163.62% | +311.93% | +325.72% | - | 8.85B | |
| -7.79% | -1.34% | +12.61% | +36.43% | +187.30% | +514.76% | +573.49% | -46.29% | -16.71% | 8.98B | |
| -3.62% | -15.34% | +4.49% | -4.24% | +276.26% | +171.90% | +167.99% | -33.42% | - | 8.1B | |
| Average | -1.77% | -0.50% | +19.41% | +8.38% | +39.92% | +87.35% | +212.42% | +182.24% | +1,055.95% | 17.39B | |
| Weighted average by Cap. | -1.94% | -0.40% | +16.77% | +10.88% | +32.11% | +71.44% | +188.77% | +178.32% | +2,112.10% |
- Stock Market
- Stocks
- ADCT Stock
- Sector ADC Therapeutics SA
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
